基本信息
views: 335

Bio
He is a Fellow of the American Statistical Association (ASA) and the Society for Clinical Trials, and received the Owen Award in 2014. Dr. Thall has pioneered the application of Bayesian methods in medical research. He is an author of over 260 papers and book chapters in the statistical and medical literature, co-authored the 2016 Chapman & Hall book "Bayesian Designs for Phase I-II Clinical Trials" and authored the 2020 Springer book ‘Statistical Remedies for Medical Researchers.’ He has designed hundreds of clinical trials in numerous areas of oncology. He has presented over 230 invited talks, and 34 short courses, served as an Associate Editor for J. National Cancer Institute, Statistics in Medicine, Statistics in Biosciences, Clinical Trials, and Biometrics, and is an ASA Media Expert.
Research Interests
Papers共 514 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Cancersno. 12 (2025): 1902
S. McGovern, J. Johnson, D. Luo, K. Nguyen,M. McAleer,A. Paulino,D. Grosshans, P. Baxter,W. Zaky,P. Thall,A. Mahajan
International Journal of Radiation OncologyBiologyPhysicsno. 3 (2025): e13-e14
Clinical cancer research an official journal of the American Association for Cancer Researchno. 6 (2025): 975-982
Transplantation and Cellular Therapyno. 2 (2024)
Bayesian Precision Medicinepp.1-28, (2024)
Bayesian Precision Medicinepp.29-54, (2024)
Bayesian Precision Medicinepp.55-110, (2024)
Bayesian Precision Medicinepp.226-241, (2024)
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2024): S241-S242
Load More
Author Statistics
#Papers: 514
#Citation: 21470
H-Index: 78
G-Index: 136
Sociability: 8
Diversity: 3
Activity: 56
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn